The North American cell counting market is projected to grow at a significant CAGR during the forecast period (2020-2026). The market is mainly driven due to the growing demand for cell-based techniques for drug discovery and clinical research applications in the region.
The significant presence of major biotechnology and biopharmaceutical companies such as Corning, Inc. and Thermo Fisher Scientific, Inc. in the region, is primarily contributing towards the growing adoption of cell-based technology in the region. A significant number of cancer cases have been registered in the US in recent years. Cell counting techniques are adopted for the research and treatment of diseases several diseases such as cancer and others that further propel the market growth.
(Get 15% Discount on Buying this Report)
A full report of North American Cell Counting Market is available at: https://www.omrglobal.com/industry-reports/north-american-cell-counting-market
The increase in the mortality rate of cancer patients in North America plays an important role, as a lot of research and development going on for the development of personalized medicine. Personalized medicine tends to treat a person decreasing the side effects by utilizing therapies and biomarkers for various forms of cancers such as ovarian cancer, breast cancer, lung cancer, prostate cancer, and oral cancer.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-cell-counting-market
The high healthcare expenditure plays an important role in the development of cancer-based therapies and personalized drugs. Moreover, according to the National Cancer Institute in 2017, estimated national expenditures for cancer care in the US was $147.3 billion. The growing expenditure for cancer is further projected to provide ample opportunity to the cell counting industry.
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Product Type, by Application, and by End-User
- Regions Covered- US and Canada
- Key Companies Profiled- Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Danahar Corp., Thermo Fisher Scientific Inc., Perkinelmer, Inc., and others
Key Questions Addressed by the Report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
North American Cell Counting Market – Segmentation
By Product Type
- Instruments
- Consumables
By Application
- Medical Applications
- Research
- Industrial
By End-User
- Pharmaceuticals and Biotechnology companies
- Research Institutes and CRO
- Hospitals and Diagnostic Laboratories
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
